Publikationen

 

Waggoner SN, Cornberg M, Selin LK, Welsh RM.
Natural killer cells act as rheostats modulating antiviral T cells.
Nature. 2011 Nov 20. doi: 10.1038/nature10624. PMID: 22101430

 

Petersen J, Ratziu V, Buti M, Janssen HL, Brown A, Lampertico P, Schollmeyer J, Zoulim F, Wedemeyer H, Sterneck M, Berg T, Sarrazin C, Lutgehetmann M, Buggisch P.
Entecavir Plus Tenofovir Combination as Rescue Therapy in Pretreated Chronic Hepatitis B Patients. An International Multicenter Cohort Study.
J Hepatol. 2011 Oct 26. PMID: 22037226

 

Suneetha PV, Pischke S, Schlaphoff V, Grabowski J, Fytili P, Gronert Alvarez A, Bremer B, Markova A, Jaroszewicz J, Bara C, Manns MP, Cornberg M, Wedemeyer H.
HEV-specific T-cell responses are associated with control of HEV infection.
Hepatology. 2011 Oct 17. doi: 10.1002/hep.24738. PMID: 22006345

 

Voigtländer T, Cornberg M, Kubitz R, Schlue J, Manns MP, Lankisch T.
Unexplained jaundice after squirrel bite. It's not what you look at that matters, it's what you see (H. D. Thoreanu).
J Gastrointestin Liver Dis. 2011 Sep;20(3):331-2. PMID: 21961108

 

Hatzakis A, Wait S, Bruix J, Buti M, Carballo M, Cavaleri M, Colombo M, Delarocque-Astagneau E, Dusheiko G, Esmat G, Esteban R, Goldberg D, Gore C, Lok AS, Manns M, Marcellin P, Papatheodoridis G, Peterle A, Prati D, Piorkowsky N, Rizzetto M, Roudot-Thoraval F, Soriano V, Thomas HC, Thursz M, Valla D, van Damme P, Veldhuijzen IK, Wedemeyer H, Wiessing L, Zanetti AR, Janssen HL.
The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*.
J Viral Hepat. 2011 Sep;18 Suppl 1:1-16. doi: 10.1111/j.1365-2893.2011.01499.x. PMID: 21824223

 

Jaroszewicz J, Ho H, Markova A, Deterding K, Wursthorn K, Schulz S, Bock CT, Tillmann HL, Manns MP, Wedemeyer H, Cornberg M.
Hepatitis B surface antigen (HBsAg) decrease and serum interferon-inducible protein-10 levels as predictive markers for HBsAg loss during treatment with nucleoside/nucleotide analogues.
Antivir Ther. 2011;16(6):915-24. PMID: 21900724

 

Pischke S, Heim A, Bremer B, Raupach R, Horn-Wichmann R, Ganzenmueller T, Klose B, Goudeva L, Wagner F, Oehme A, Manns MP, Wedemeyer H.
Hepatitis E: an emerging infectious disease in Germany?
Z Gastroenterol. 2011 Sep;49(9):1255-7. Epub 2011 Sep 1. PMID: 21887661

 

Zacher BJ, Moriconi F, Bowden S, Hammond R, Louisirirotchanakul S, Phisalprapa P, Tanwandee T, Wursthorn K, Brunetto MR, Wedemeyer H, Bonino F.
Multicenter evaluation of the elecsys hepatitis B surface antigen quantitative assay.
Clin Vaccine Immunol. 2011 Nov;18(11):1943-50. Epub 2011 Aug 31. PMID: 21880853

 

Ciesek S, von Hahn T, Colpitts CC, Schang LM, Friesland M, Steinmann J, Manns MP, Ott M, Wedemeyer H, Meuleman P, Pietschmann T, Steinmann E.
The green tea polyphenol epigallocatechin-3-gallate (EGCG) inhibits hepatitis C virus (HCV) entry.
Hepatology. 2011 Aug 11. doi: 10.1002/hep.24610. PMID: 21837753

 

Si-Ahmed SN, Pradat P, Zoutendijk R, Buti M, Mallet V, Cruiziat C, Deterding K, Dumortier J, Bailly F, Esteban R, Wedemeyer H, Janssen HL, Zoulim F.
Efficacy and tolerance of a combination of tenofovir disoproxil fumarate plus emtricitabine in patients with chronic hepatitis B: a European multicenter study.
Antiviral Res. 2011 Oct;92(1):90-5. Epub 2011 Jul 13. PMID: 21767570

 

Mederacke I, Filmann N, Yurdaydin C, Bremer B, Puls F, Zacher BJ, Heidrich B, Tillmann HL, Rosenau J, Bock CT, Savas B, Helfritz F, Lehner F, Strassburg CP, Klempnauer J, Wursthorn K, Lehmann U, Manns MP, Herrmann E, Wedemeyer H.
Rapid early HDV RNA decline in the peripheral blood but prolonged intrahepatic hepatitis delta antigen persistence after liver transplantation.
J Hepatol. 2011 Jul 14. PMID: 21762665

 

Grabowski J, Yurdaydìn C, Zachou K, Buggisch P, Hofmann WP, Jaroszewicz J, Schlaphoff V, Manns MP, Cornberg M, Wedemeyer H; the HIDIT-1 study group.
Hepatitis D virus-specific cytokine responses in patients with chronic hepatitis delta before and during interferon alfa-treatment.
Liver Int. 2011 Jul 15. doi: 10.1111/j.1478-3231.2011.02593.x. PMID: 21762356

 

Cornberg M, Protzer U, Petersen J, Wedemeyer H, Berg T, Jilg W, Erhardt A, Wirth S, Sarrazin C, Dollinger MM, Schirmacher P, Dathe K, Kopp IB, Zeuzem S, Gerlich WH, Manns MP; AWMF.
[Prophylaxis, diagnosis and therapy of hepatitis B virus infection - the German guideline].
Z Gastroenterol. 2011 Jul;49(7):871-930. Epub 2011 Jul 11. PMID: 21748700

 

Chan HL, Thompson A, Martinot-Peignoux M, Piratvisuth T, Cornberg M, Brunetto MR, Tillmann HL, Kao JH, Jia JD, Wedemeyer H, Locarnini S, Janssen HL, Marcellin P; for the Good Practice in using sAg in Chronic Hepatitis B Study Group (GPs-CHB Study Group).
Hepatitis B surface antigen Quantification: Why and How to use it in 2011 - A Core Group Report.
J Hepatol. 2011 Nov;55(5):1121-31. Epub 2011 Jun 28. PMID: 21718667

 

Nattermann J, Timm J, Nischalke HD, Olbrich A, Michalk M, Tilmann HL, Berg T, Wedemeyer H, Tenckhoff H, Wiese M, Kullig U, Göbel U, Capka E, Schiefke I, Güthoff W, Grüngreiff K, König I, Roggendorf M, Sauerbruch T, Spengler U; for the East German HCV study group.
The predictive value of IL28B gene polymorphism for spontaneous clearance in a single source outbreak cohort is limited in patients carrying the CCR5Δ32 mutation.
J Hepatol. 2011 Apr 13. PMID: 21703201

 

Jacobson IM, McHutchison JG, Dusheiko G, Di Bisceglie AM, Reddy KR, Bzowej NH, Marcellin P, Muir AJ, Ferenci P, Flisiak R, George J, Rizzetto M, Shouval D, Sola R, Terg RA, Yoshida EM, Adda N, Bengtsson L, Sankoh AJ, Kieffer TL, George S, Kauffman RS, Zeuzem S; ADVANCE Study Team.
Telaprevir for previously untreated chronic hepatitis C virus infection.
N Engl J Med. 2011 Jun 23;364(25):2405-16. PMID: 21696307

 

Deterding K, Naesens L, Buti M, Janssen H, Kirschner J, Guerrero A, Reijnders J, Neyts J, Zoulim F, Wedemeyer H.
Adefovir serum levels do not differ between responders and nonresponders.
J Viral Hepat. 2011 Jul;18(7):e175-8. doi: 10.1111/j.1365-2893.2010.01404.x. Epub 2011 Jan 7. PMID: 21692930

 

von Hahn T, Ciesek S, Wegener G, Plentz RR, Weismüller TJ, Wedemeyer H, Manns MP, Greten TF, Malek NP.
Epidemiological trends in incidence and mortality of hepatobiliary cancers in Germany.
Scand J Gastroenterol. 2011 Sep;46(9):1092-8. Epub 2011 Jun 22. PMID: 21692710

 

Cornberg M, Razavi HA, Alberti A, Bernasconi E, Buti M, Cooper C, Dalgard O, Dillion JF, Flisiak R, Forns X, Frankova S, Goldis A, Goulis I, Halota W, Hunyady B, Lagging M, Largen A, Makara M, Manolakopoulos S, Marcellin P, Marinho RT, Pol S, Poynard T, Puoti M, Sagalova O, Sibbel S, Simon K, Wallace C, Young K, Yurdaydin C, Zuckerman E, Negro F, Zeuzem S.
A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel.
Liver Int. 2011 Jul;31 Suppl 2:30-60. PMID: 21651702

 

Ciesek S, Westhaus S, Wicht M, Wappler I, Henschen S, Sarrazin C, Hamdi N, Abdelaziz AI, Strassburg CP, Wedemeyer H, Manns MP, Pietschmann T, von Hahn T.
Impact of occludin intra- and inter-species variation on its co-receptor function for authentic hepatitis C virus particles.
J Virol. 2011 Aug;85(15):7613-21. Epub 2011 Jun 1. PMID: 21632765

 

Schlaphoff V, Lunemann S, Suneetha PV, Jaroszewicz J, Grabowski J, Dietz J, Helfritz F, Bektas H, Sarrazin C, Manns MP, Cornberg M, Wedemeyer H.
Dual Function of the NK Cell Receptor 2B4 (CD244) in the Regulation of HCV-Specific CD8+ T Cells.
PLoS Pathog. 2011 May;7(5):e1002045. PMID: 21625589

 

Zoutendijk R, Reijnders JG, Brown A, Zoulim F, Mutimer D, Deterding K, Petersen J, Hofmann WP, Buti M, Santantonio T, van Bömmel F, Pradat P, Oo Y, Luetgehetmann M, Berg T, Hansen BE, Wedemeyer H, Janssen HL; for the VIRGIL Surveillance Study Group.
Entecavir treatment for chronic hepatitis B: Adaptation is not needed for the majority of naïve patients with a partial virological response.
Hepatology. 2011 Aug;54(2):443-51. doi: 10.1002/hep.24406. PMID: 21563196

 

Rockstroh JK, Peters L, Wedemeyer H.
Is there a need for liver disease monitoring in HIV patients in Africa?
Antivir Ther. 2011;16(3):287-9. PMID: 21555810

 

Hartmann D, Srivastava U, Thaler M, Kleinhans KN, N'kontchou G, Scheffold A, Bauer K, Kratzer RF, Kloos N, Katz SF, Song Z, Begus-Nahrmann Y, Kleger A, von Figura G, Strnad P, Lechel A, Günes C, Potthoff A, Deterding K, Wedemeyer H, Ju Z, Song G, Xiao F, Gillen S, Schrezenmeier H, Mertens T, Ziol M, Friess H, Jarek M, Manns MP, Beaugrand M, Rudolph KL.
Telomerase gene mutations are associated with cirrhosis formation.
Hepatology. 2011 May;53(5):1608-17. doi: 10.1002/hep.24217. PMID: 21520174

 

Li Y, Mederacke I, Scheumann GF, Baraki H, Wedemeyer H, Kutschka I.
Simultaneous Mitral Valve Replacement and Liver Transplantation.
Thorac Cardiovasc Surg. 2011 Apr 21. PMID: 21512977

 

Hughes SA, Wedemeyer H, Harrison PM.
Hepatitis delta virus.
Lancet. 2011 Jul 2;378(9785):73-85. Epub 2011 Apr 20.  PMID: 21511329

 

Trépo E, Pradat P, Potthoff A, Momozawa Y, Quertinmont E, Gustot T, Lemmers A, Berthillon P, Amininejad L, Chevalier M, Devière J, Manns M, Trépo C, Sninsky J, Wedemeyer H, Franchimont D, Moreno C.
Impact of PNPLA3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C.
Hepatology. 2011 Jul;54(1):60-9. doi: 10.1002/hep.24350. PMID: 21488075

 

Bacon BR, Gordon SC, Lawitz E, Marcellin P, Vierling JM, Zeuzem S, Poordad F, Goodman ZD, Sings HL, Boparai N, Burroughs M, Brass CA, Albrecht JK, Esteban R; HCV RESPOND-2 Investigators.
Boceprevir for previously treated chronic HCV genotype 1 infection.
N Engl J Med. 2011 Mar 31;364(13):1207-17. PMID: 21449784

 

Rifai K, Cornberg J, Mederacke I, Bahr MJ, Wedemeyer H, Malinski P, Bantel H, Boozari B, Potthoff A, Manns MP, Gebel M.
Clinical feasibility of liver elastography by acoustic radiation force impulse imaging (ARFI).
Dig Liver Dis. 2011 Jun;43(6):491-7. Epub 2011 Mar 24. PMID: 21439919

 

Wursthorn K, Wedemeyer H, Manns MP.
Republished paper: Managing HBV in patients with impaired immunity.
Postgrad Med J. 2011 Mar;87(1025):223-38. PMID: 21357572

 

Cornberg M, Manns MP.
[Prevention of virus hepatitis A to E].
Internist (Berl). 2011 Mar;52(3):250-64. German.
PMID: 21340533

 

Pischke S, Karsten W, Hadem J, Schmidt S, Heiringhoff Heinz K, Helfritz F,
Strassburg CP, Lobers J, Zender L, Tutarel O, Wedemeyer J, Manns MP, Wedemeyer H, Rifai K, Gebel M.
Liver transplantation: A new risk factor for intestinal intussusceptions.
Ann Hepatol. 2011 Jan 3;10(1):38-42. PMID: 21301008.

 

Mederacke I, Meier M, Lüth JB, Schmidt-Gürtler H, Raupach R, Horn-Wichmann R,
Wursthorn K, Potthoff A, Colucci G, Manns MP, Wedemeyer H, Tillmann HL.
Different kinetics of HBV and HCV during haemodialysis and absence of seronegative viral hepatitis in patients with end-stage renal disease.
Nephrol Dial Transplant. 2011 Aug;26(8):2648-56. Epub 2011 Jan 27. PMID: 21273235.

 

Wursthorn K, Jaroszewicz J, Zacher BJ, Darnedde M, Raupach R, Mederacke I,
Cornberg M, Manns MP, Wedemeyer H.
Correlation between the Elecsys HBsAg II assay and the Architect assay for the quantification of hepatitis B surface antigen (HBsAg) in the serum.
J Clin Virol. 2011 Apr;50(4):292-6. Epub 2011 Jan 26. PMID: 21273117.

 

Wedemeyer H, Yurdaydìn C, Dalekos GN, Erhardt A, Çakaloğlu Y, Değertekin H, Gürel S, Zeuzem S, Zachou K, Bozkaya H, Koch A, Bock T, Dienes HP, Manns MP; HIDIT Study Group.
Peginterferon plus adefovir versus either drug alone for hepatitis delta.
N Engl J Med. 2011 Jan 27;364(4):322-31. PMID: 21268724.

 

Wedemeyer H.
Hepatitis D revival.
Liver Int. 2011 Jan;31 Suppl 1:140-4. PMID: 21205152.

 

Manns M, Zeuzem S, Sood A, Lurie Y, Cornberg M, Klinker H, Buggisch P, Rössle M, Hinrichsen H, Merican I, Ilan Y, Mauss S, Abu-Mouch S, Horban A, Müller TH, Welsch C, Chen R, Faruqi R, Pedicone LD, Wedemeyer H.
Reduced Dose and Duration of Peginterferon alfa-2b and Weight-Based Ribavirin in Patients With Genotype 2 and 3 Chronic Hepatitis C.
J Hepatol. 2011 Sep;55(3):554-63. Epub 2011 Jan 13. PMID: 21237227.

 

Torresi J, Johnson D, Wedemeyer H.
Progress in the development of preventive and therapeutic vaccines for hepatitis C virus.
J Hepatol. 2011 Jun;54(6):1273-85. Epub 2011 Jan 12 PMID: 21236312.

 

Wedemeyer H, Pischke S.
Hepatitis: Hepatitis E vaccination--is HEV 239 the breakthrough?
Nat Rev Gastroenterol Hepatol. 2011 Jan;8(1):8-10. PMID: 21212772.

 

Cornberg M, Manns MP.
[Current Guidelines for treatment of hepatitis B. Correct diagnosis is the prerequisite.].
Pharm Unserer Zeit. 2011 Jan;40(1):45-51.
PMID: 21194082

 
Wursthorn K, Zacher BJ, Jaroszewicz J, Darnedde M, Manns M, Wedemeyer H.
Development of a protocol for the quantitative determination of HBeAg using the
Elecsys HBeAg immunoassay.
J Viral Hepat. 2010 Dec 30. PMID: 21199189.

 

Trépo E, Potthoff A, Pradat P, Bakshi R, Young B, Lagier R, Moreno C, Verset L, Cross R, Degré D, Lemmers A, Gustot T, Berthillon P, Rosenberg W, Trépo C, Sninsky J, Adler M, Wedemeyer H.
Role of a cirrhosis risk score for the early prediction of fibrosis progression in hepatitis C patients with minimal liver disease.
J Hepatol. 2010 Nov 23. PMID: 21145859

 

Cornberg M, Jaroszewicz J, Manns MP, Wedemeyer H.
Treatment of chronic hepatitis B.
Minerva Gastroenterol Dietol. 2010 Dec;56(4):451-65.PMID: 21139543

 

Mederacke I, Witte T, Wedemeyer H, Meyer-Olson D.
Successful clearance of hepatitis C virus with pegylated interferon {alpha}-2a and ribavirin in an etanercept-treated patient with psoriatic arthritis, hepatitis B virus coinfection and latent tuberculosis.
Ann Rheum Dis. 2010 Dec 3.  PMID: 21131645

 

Wedemeyer H.
From volcano clouds to iLivers: EASL growing in times of change.
J Hepatol. 2011 Jan;54(1):4-5. PMID: 21115150

 

Boozari B, Potthoff A, Mederacke I, Hahn A, Reising A, Rifai K, Wedemeyer H, Bahr M, Kubicka S, Manns M, Gebel M.

Evaluation of sound speed for detection of liver fibrosis: prospective comparison with transient dynamic elastography and histology.
J Ultrasound Med. 2010 Nov;29(11):1581-8.PMID: 20966469

 

Becker PD, Legrand N, van Geelen CM, Noerder M, Huntington ND, Lim A, Yasuda E, Diehl SA, Scheeren FA, Ott M, Weijer K, Wedemeyer H, Di Santo JP, Beaumont T, Guzman CA, Spits H.
Generation of human antigen-specific monoclonal IgM antibodies using vaccinated "human immune system" mice.
PLoS One. 2010 Oct 4;5(10). pii: e13137.PMID: 20957227

 

Wursthorn K, Jung M, Riva A, Goodman ZD, Lopez P, Bao W, Manns MP, Wedemeyer H, Naoumov NV.
Kinetics of hepatitis B surface antigen decline during 3 years of telbivudine treatment in hepatitis B e antigen-positive patients.
Hepatology. 2010 Nov;52(5):1611-20.PMID: 20931556

 

Ernst D, Pischke S, Greer M, Wedemeyer HH, Stoll M.
No increased incidence for GB-Virus C infection in a cohort of HIV-positive Lymphoma patients.
Int J Cancer. 2010 Aug 19.  PMID: 20726003

 

Tillmann HL, Thompson AJ, Patel K, Wiese M, Tenckhoff H, Nischalke HD, Lokhnygina Y, Kullig U, Göbel U, Capka E, Wiegand J, Schiefke I, Güthoff W, Grüngreiff K, König I, Spengler U, McCarthy J, Shianna KV, Goldstein DB, McHutchison JG, Timm J, Nattermann J; German Anti-D Study Group.
A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice.
Gastroenterology. 2010 Nov;139(5):1586-92, 1592.e1. .PMID: 20637200

 

Bürgel B, Friesland M, Koch A, Manns MP, Wedemeyer H, Weissenborn K, Schulz-Schaeffer WJ, Pietschmann T, Steinmann E, Ciesek S.
Hepatitis C virus enters human peripheral neuroblastoma cells - evidence for extra-hepatic cells sustaining hepatitis C virus penetration.
J Viral Hepat. 2010 Jun 23. PMID: 20579278

 

Wursthorn K, Wedemeyer H, Manns MP.
Managing HBV in patients with impaired immunity.
Gut. 2010 Jun 4. PMID: 20525968

 

Pischke S, Potthoff A, Hauröder B, Schlué J, Manns MP, Cornberg M, Wedemeyer H.
[Hepatitis E virus infection: a paradigm shift?]
Dtsch Med Wochenschr. 2010 Jun;135(22):1129-33. Epub 2010 May 25. Review. German. PMID: 20503140

 

Pischke S, Wedemeyer H.
Chronic hepatitis E in liver transplant recipients: a significant clinical problem?
Minerva Gastroenterol Dietol. 2010 Jun;56(2):121-8.PMID: 20485250

 

Grabowski J, Wedemeyer H.
Hepatitis delta: immunopathogenesis and clinical challenges.
Dig Dis. 2010;28(1):133-8. Epub 2010 May 7. PMID: 20460901

 

Ciesek S, Friesland M, Steinmann J, Becker B, Wedemeyer H, Manns MP, Steinmann J, Pietschmann T, Steinmann E.
How Stable Is the Hepatitis C Virus (HCV)? Environmental Stability of HCV and Its Susceptibility to Chemical Biocides.
J Infect Dis. 2010 May 4. PMID: 20441517

 

Mederacke I, Bremer B, Heidrich B, Kirschner J, Deterding K, Bock T, Wursthorn K, Manns MP, Wedemeyer H.
Establishment of a novel quantitative HDV RNA assay using the COBAS TaqMan platform to study HDV RNA kinetics.
J Clin Microbiol. 2010 Mar 29. PMID: 20351206

 

Wedemeyer H.
Re-emerging interest in hepatitis delta: new insights into the dynamic interplay between HBV and HDV.
J Hepatol. 2010 May;52(5):627-9. Epub 2010 Mar 4. No abstract available. PMID: 20334947

 

Stegmann KA, Björkström NK, Veber H, Ciesek S, Riese P, Wiegand J, Hadem J, Suneetha PV, Jaroszewicz J, Wang C, Schlaphoff V, Fytili P, Cornberg M, Manns MP, Geffers R, Pietschmann T, Guzmán CA, Ljunggren HG, Wedemeyer H.
Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection.
Gastroenterology. 2010 May;138(5):1885-97. Epub 2010 Feb 2. PMID: 20334827

 

Jaroszewicz J, Serrano BC, Wursthorn K, Deterding K, Schlue J, Raupach R, Flisiak R, Bock CT, Manns MP, Wedemeyer H, Cornberg M.
Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: A European perspective.
J Hepatol. 2010 Feb 13. PMID: 20207438

 

Cornberg M, Clute SC, Watkin LB, Saccoccio FM, Kim SK, Naumov YN, Brehm MA, Aslan N, Welsh RM, Selin LK.
CD8 T cell cross-reactivity networks mediate heterologous immunity in human EBV and murine vaccinia virus infections.
J Immunol. 2010 Mar 15;184(6):2825-38. Epub 2010 Feb 17.PMID: 20164414

 

Mederacke I, Wursthorn K, Ho H, Manns MP, Wedemeyer H.
[Interferon-alfa induced reactivation of sarcoidosis in a patient with chronic hepatitis C.]
Internist (Berl). 2010 Feb 27.  German. PMID: 20186385

 

Reijnders JG, Deterding K, Petersen J, Zoulim F, Santantonio T, Buti M, van Bömmel F, Hansen BE, Wedemeyer H, Janssen HL; for the VIRGIL Surveillance Study Group.
Antiviral effect of entecavir in chronic hepatitis B: Influence of prior exposure to nucleos(t)ide analogues.
J Hepatol. 2010 Feb 4. PMID: 20185191

 

Potthoff A, Manns MP, Wedemeyer H.
Treatment of HBV/HCV coinfection.
Expert Opin Pharmacother. 2010 Feb 18. PMID: 20166841

 

Ciesek S, Steinmann E, Iken M, Ott M, Helfritz FA, Wappler I, Manns MP, Wedemeyer H, Pietschmann T.
Glucocorticosteroids Increase Cell Entry by Hepatitis C Virus.
Gastroenterology. 2010 Feb 10. PMID: 20152835

 

Stange MA, Tutarel O, Pischke S, Schneider A, Strassburg CP, Becker T, Barg-Hock H, Bastürk M, Wursthorn K, Cornberg M, Ott M, Greten TF, Manns MP, Wedemeyer H.
Fulminant Hepatic Failure due to Chemotherapy-Induced Hepatitis B Reactivation: Role of Rituximab.
Z Gastroenterol. 2010 Feb;48(2):258-263. Epub 2010 Feb 2.PMID: 20127601

 

Sarrazin C, Berg T, Ross RS, Schirmacher P, Wedemeyer H, Neumann U, Schmidt HH, Spengler U, Wirth S, Kessler HH, Peck-Radosavljevic M, Ferenci P, Vogel W, Moradpour D, Heim M, Cornberg M, Protzer U, Manns MP, Fleig WE, Dollinger MM, Zeuzem S.
Prophylaxis, Diagnosis and Therapy of Hepatitis C Virus (HCV) Infection: The German Guidelines on the Management of HCV Infection.
Z Gastroenterol. 2010 Feb;48(2):289-351. Epub 2010 Jan 29. No abstract available. PMID: 20119896

 

Wedemeyer H, Hofmann WP, Lueth S, Malinski P, Thimme R, Tacke F, Wiegand J.
[ALT screening for chronic liver diseases: scrutinizing the evidence]
Z Gastroenterol. 2010 Jan;48(1):46-55. Epub 2010 Jan 13. German. PMID: 20072996

 

Pischke S, Ehmer U, Schedel I, Gratz WF, Wedemeyer H, Ziesing S, Bange FC, Burchard GD, Manns MP, Bahr MJ, Strassburg CP.
Of guinea pigs and men--an unusual case of jaundice.
Z Gastroenterol. 2010 Jan;48(1):33-7. Epub 2010 Jan 13.PMID: 20072994

 

Wedemeyer H, Manns MP.
Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead.
Nat Rev Gastroenterol Hepatol. 2010 Jan;7(1):31-40.PMID: 20051970

 

Pischke S, Ho H, Urbanek F, Meyer-Olsen D, Suneetha PV, Manns MP, Stoll M, Wedemeyer H.
Hepatitis E in HIV-positive patients in a low-endemic country.
J Viral Hepat. .  No abstract available. PMID: 20002566

 

van Bömmel F, de Man RA, Wedemeyer H, Deterding K, Petersen J, Buggisch P, Erhardt A, Hüppe D, Stein K, Trojan J, Sarrazin C, Böcher WO, Spengler U, Wasmuth HE, Reinders JG, Möller B, Rhode P, Feucht HH, Wiedenmann B, Berg T.
Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside/nucleotide analogues.
Hepatology. 2010 Jan;51(1):73-80.PMID: 19998272

 

 

Ciesek S, Rifai K, Bahr MJ, Boozari B, Steinmann E, Helfritz FA, Wedemeyer H, Manns MP, Gebel M.
Membranous Budd-Chiari syndrome in Caucasians.
Scand J Gastroenterol. 2010;45(2):226-34. PMID: 19958053

 

Jirmo AC, Koya RC, Sundarassety BS, Pincha M, Yu GY, Lai M, Bakshi R, Schlaphoff V, Grabowski J, Behrens G, Wedemeyer H, Stripecke R.
Monocytes transduced with lentiviral vectors expressing hepatitis C virus non-structural proteins and differentiated into dendritic cells stimulate multi-antigenic CD8(+) T cell responses.
Vaccine. 2010 Jan 22;28(4):922-33. Epub 2009 Nov 18. PMID: 19931383

 

Strassburg CP, Cornberg M.
[Diagnostics and therapy of hepatitis.]
Internist (Berl). 2009 Dec;50(12):1358-68. PMID: 19921110

 

Beckmann MG, Bahr MJ, Hadem J, Bredt M, Wedemeyer H, Schneider AS, Kubicka S, Manns MP, Strassburg CP, Wedemeyer J.
Clinical relevance of transjugular liver biopsy in comparison with percutaneous and laparoscopic liver biopsy.
Gastroenterol Res Pract. 2009;2009:947014. Epub 2009 Nov 15.PMID: 19920868

 

Wedemeyer H.
EASL transitioning into the new decade.
J Hepatol. 2009 Oct 29. PMID: 19910072

 

Potthoff A, Berg T, Wedemeyer H.
Late hepatitis B virus relapse in patients co-infected with hepatitis B virus and hepatitis C virus after antiviral treatment with pegylated interferon-a2b and ribavirin.
Scand J Gastroenterol. 2009;44(12):1487-90. PMID: 19900055

 

Wiegand J, Meya S, Schlaphoff V, Manns MP, Mössner J, Wedemeyer H, Tillmann HL.
HBV-specific T-cell responses in healthy seronegative sexual partners of patients with chronic HBV infection.
J Viral Hepat. 2009 Nov 2. PMID: 19889141

 

Pischke S, Suneetha P, Baechlein C, Barg-Hock H, Heim A, Kamar N, Schlue J, Strassburg C, Lehner F, Raupach R, Bremer B, Magerstedt P, Cornberg M, Seehusen F, Baumgaertner W, Klempnauer J, Izopet J, Manns M, Grummer B, Wedemeyer H.
Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients.
Liver Transpl. 2010 Jan;16(1):74-82. PMID: 19866448

 

Wang C, Heim A, Schlaphoff V, Suneetha PV, Stegmann KA, Jiang H, Krueger M, Fytili P, Schulz T, Cornberg M, Kandolf R, Manns MP, Bock CT, Wedemeyer H.
Intrahepatic long-term persistence of parvovirus B19 and its role in chronic viral hepatitis.
J Med Virol. 2009 Dec;81(12):2079-88 PMID: 19856479

 

Nie S, Cornberg M, Selin LK.
Resistance to vaccinia virus is less dependent on TNF under conditions of heterologous immunity.
J Immunol. 2009 Nov 15;183(10):6554-60. Epub 2009 Oct 21.PMID: 19846867

 

Deterding K, Grüngreiff K, Lankisch TO, Potthoff A, Bahr MJ, Manns MP, Wedemeyer H, Strassburg CP.
Gilbert's syndrome and antiviral therapy of hepatitis C.
Ann Hepatol. 2009 Jul-Sep;8(3):246-50. PMID: 19841506

 

Zachou K, Yurdaydin C, Drebber U, Dalekos GN, Erhardt A, Cakaloglu Y, Degertekin H, Gurel S, Zeuzem S, Bozkaya H, Schlaphoff V, Dienes HP, Bock TC, Manns MP, Wedemeyer H; for HIDT-1 Study Group.
Quantitative HBsAg and HDV-RNA levels in chronic delta hepatitis.
Liver Int. 2009 Oct 15. [Epub ahead of print] PMID: 19840253

 

Pradat P, Trepo E, Potthoff A, Bakshi R, Young B, Trepo C, Lagier R, Moreno C, Lemmers A, Gustot T, Degre D, Adler M, Wedemeyer H.
The cirrhosis risk score predicts liver fibrosis progression in patients with initially mild chronic hepatitis C.
Hepatology. 2010 Jan;51(1):356-7. PMID: 19824080

 

Ciesek S, Steinmann E, Wedemeyer H, Manns MP, Neyts J, Tautz N, Madan V, Bartenschlager R, von Hahn T, Pietschmann T.
Cyclosporine A inhibits hepatitis C virus nonstructural protein 2 through cyclophilin A.
Hepatology. 2009 Nov;50(5):1638-45. PMID: 19821520

 

Mederacke I, Wedemeyer H, Ciesek S, Steinmann E, Raupach R, Wursthorn K, Manns MP, Tillmann HL.
Performance and clinical utility of a novel fully automated quantitative HCV-core antigen assay.
J Clin Virol. 2009 Nov;46(3):210-5. Epub 2009 Sep 17. PMID: 19766055

 

Mederacke I, Wursthorn K, Kirschner J, Rifai K, Manns MP, Wedemeyer H, Bahr MJ.
Food intake increases liver stiffness in patients with chronic or resolved hepatitis C virus infection.
Liver Int. 2009 Nov;29(10):1500-6. Epub 2009 Sep 3. PMID: 19732330

 

Haridass D, Yuan Q, Becker PD, Cantz T, Iken M, Rothe M, Narain N, Bock M, Nörder M, Legrand N, Wedemeyer H, Weijer K, Spits H, Manns MP, Cai J, Deng H, Di Santo JP, Guzman CA, Ott M.
Repopulation efficiencies of adult hepatocytes, fetal liver progenitor cells, and embryonic stem cell-derived hepatic cells in albumin-promoter-enhancer urokinase-type plasminogen activator mice.
Am J Pathol. 2009 Oct;175(4):1483-92. Epub 2009 Aug 28.PMID: 19717639

 

Potthoff A, Rifai K, Wedemeyer H, Deterding K, Manns M, Strassburg C.
Successful treatment of fulminant hepatitis B during pregnancy.
Z Gastroenterol. 2009 Jul;47(7):667-70. Epub 2009 Jul 15.PMID: 19606409

 

Heidrich B, Deterding K, Tillmann HL, Raupach R, Manns MP, Wedemeyer H. Virological and clinical characteristics of delta hepatitis in Central Europe.J Viral Hepat. 2009 Dec;16(12):883-94. Epub 2009 Jun 28. PMID: 19566789

 

Wedemeyer H, Schuller E, Schlaphoff V, Stauber RE, Wiegand J, Schiefke I, Firbas C, Jilma B, Thursz M, Zeuzem S, Hofmann WP, Hinrichsen H, Tauber E, Manns MP, Klade CS.
Therapeutic vaccine IC41 as late add-on to standard treatment in patients with chronic hepatitis C.
Vaccine. 2009 Aug 13;27(37):5142-51. Epub 2009 Jun 24 PMID: 19559112

 

Hoechst B, Voigtlaender T, Ormandy L, Gamrekelashvili J, Zhao F, Wedemeyer H, Lehner F, Manns MP, Greten TF, Korangy F.
Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor.
Hepatology. 2009 Sep;50(3):799-807 PMID: 19551844

 

Dintsios CM, Haverkamp A, Wiegand J, Gerlach T, Wedemeyer H, Pape G, Manns MP, Krauth C.
Economic evaluation of early monotherapy versus delayed monotherapy or combination therapy in patients with acute hepatitis C in Germany.
Eur J Gastroenterol Hepatol. 2010 Mar;22(3):278-88 PMID: 19550347

 

Vogel M, Deterding K, Wiegand J, Grüner NH, Baumgarten A, Jung MC, Manns MP, Wedemeyer H, Rockstroh JK; German Hepatitis Group; Hep-Net.
Initial presentation of acute hepatitis C virus (HCV) infection among HIV-negative and HIV-positive individuals-experience from 2 large German networks on the study of acute HCV infection.
Clin Infect Dis. 2009 Jul 15;49(2):317-9; PMID: 19538070

 

Deterding K, Wiegand J, Grüner N, Hahn A, Jäckel E, Jung MC, Buggisch P, Galle P, Berg T, Hinrichsen H, Potthoff A, Zeuzem S, Cornberg M, Manns M, Wedemeyer H.
The German Hep-Net Acute Hepatitis C Cohort: Impact of Viral and Host Factors on the Initial Presentation of Acute Hepatitis C Virus Infection.
Z Gastroenterol. 2009 Jun;47(6):531-540. Epub 2009 Jun 16. PMID: 19533544

 

Mederacke I, Wedemeyer H.
Nitazoxanide for the treatment of chronic hepatitis C New opportunities but new challenges?
Ann Hepatol. 2009 Apr 1;8(2):166-168. PMID: 19502665

 

Potthoff A, Witte T, Rifai K, Hoy L, Deterding K, Feyerabend S, Manns MP, Wedemeyer H.
Prevalence of alpha-fodrin antibodies in patients with chronic hepatitis C infection and Sjogren syndrome.
Scand J Gastroenterol. 2009;44(8):994-1003 PMID: 19462335

 

Erhardt A, Deterding K, Benhamou Y, Reiser M, Forns X, Pol S, Calleja JL, Ross S, Spangenberg HC, Garcia-Samaniego J, Fuchs M, Enríquez J, Wiegand J, Stern J, Wu K, Kukolj G, Marquis M, Beaulieu P, Nehmiz G, Steffgen J; BILB 1941 Study Group.
Safety, pharmacokinetics and antiviral effect of BILB 1941, a novel hepatitis C virus RNA polymerase inhibitor, after 5 days oral treatment.
Antivir Ther. 2009;14(1):23-32. PMID: 19320234

 

Klade CS, Kubitschke A, Stauber RE, Meyer MF, Zinke S, Wiegand J, Zauner W, Aslan N, Lehmann M, Cornberg M, Manns MP, Reisner P, Wedemeyer H.
Hepatitis C virus-specific T cell responses against conserved regions in recovered patients.
Vaccine. 2009 May 18;27(23):3099-108. Epub 2009 Mar 11. PMID: 19428924

 

Morice Y, Ratinier M, Miladi A, Chevaliez S, Germanidis G, Wedemeyer H, Laperche S, Lavergne JP, Pawlotsky JM.
Seroconversion to hepatitis C virus alternate reading frame protein during acute infection.
Hepatology. 2009 May;49(5):1449-59. PMID: 19350656

 

Jeffe F, Stegmann KA, Broelsch F, Manns MP, Cornberg M, Wedemeyer H.
Adenosine and IFN-{alpha} synergistically increase IFN-gamma production of human NK cells.
J Leukoc Biol. 2009 Mar;85(3):452-61. Epub 2008 Dec 26. PMID: 19095736

 

Mederacke I, Wedemeyer H, Manns MP.
Boceprevir, an NS3 serine protease inhibitor of hepatitis C virus, for the treatment of HCV infection.
Curr Opin Investig Drugs. 2009 Feb;10(2):181-9. PMID: 19197796

 

Ghosh A, Koestner W, Hapke M, Schlaphoff V, Langer F, Baumann R, Koenecke C, Cornberg M, Welte K, Blazar B, Sauer M.
Donor T cells primed on leukemia lysate-pulsed recipient APCs mediate strong graft versus leukemia effects across MHC barriers in full chimeras.
Blood. 2009 Apr 30;113(18):4440-8. Epub 2009 Jan 30 PMID: 19182207

 

Suneetha PV, Schlaphoff V, Wang C, Stegmann KA, Fytili P, Sarin SK, Manns MP, Cornberg M, Wedemeyer H.
Effect of peptide pools on effector functions of antigen-specific CD8+ T cells.
J Immunol Methods. 2009 Mar 15;342(1-2):33-48. Epub 2009 Jan 9. PMID: 19135447

 

 

Wursthorn K, Manns MP, Wedemeyer H.
Natural history: the importance of viral load, liver damage and HCC.
Best Pract Res Clin Gastroenterol. 2008;22(6):1063-79. PMID: 19187867

Hadem J, Stiefel P, Bahr MJ, Wedemeyer H, Manns MP, Schneider AS.
Reply
Clin Gastroenterol Hepatol. 2008 Dec 31.  PMID: 19121646

Moenkemeyer M, Schmidt RE, Wedemeyer H, Tillmann HL, Heiken H.
GBV-C coinfection is negatively correlated to Fas expression and Fas-mediated apoptosis in HIV-1 infected patients.
J Med Virol. 2008 Nov;80(11):1933-40. PMID: 18814245

Hadem J, Cornberg M, Hauptmann C, Süttmann U, Manns MP, Wedemeyer H.
Pneumococcal meningitis during antiviral treatment with interferon and ribavirin in a splenectomized patient with chronic hepatitis C - do not miss vaccination before starting therapy.
Z Gastroenterol. 2008 Sep;46(9):880-2. Epub 2008 Sep 22. PMID: 18810674

Deterding K, Manns MP, Wedemeyer H.
Does the presence of adefovir-resistant variants lead to failure of tenofovir monotherapy?
J Hepatol. 2008 Nov;49(5):862-3. Epub 2008 Aug 19. No abstract available. PMID: 18804309

Wiegand J, Deterding K, Cornberg M, Wedemeyer H.
Treatment of acute hepatitis C: the success of monotherapy with (pegylated) interferon alpha.
J Antimicrob Chemother. 2008 Nov;62(5):860-5. Epub 2008 Sep 5. PMID: 18776191

Ciesek S, Steinmann E, Manns MP, Wedemeyer H, Pietschmann T.
The suppressive effect that myriocin has on hepatitis C virus RNA replication is independent of inhibition of serine palmitoyl transferase.
J Infect Dis. 2008 Oct 1;198(7):1091-3. No abstract available. PMID: 18774886

Cornberg M, Protzer U, Dollinger MM, Petersen J, Wedemeyer H, Berg T, Jilg W, Erhardt A, Wirth S, Schirmacher P, Fleig WE, Manns MP; German Society for Digestive and Metabolic Diseases; German Society for Pathology; Society for Virology; Society for Pediatric Gastroenterology and Nutrition; Competence Network for Viral Hepatitis.
The German guideline for the management of hepatitis B virus infection: short version.
J Viral Hepat. 2008 Aug;15 Suppl 1:1-21. No abstract available. PMID: 18713127

Zeuzem S, Berg T, Moeller B, Hinrichsen H, Mauss S, Wedemeyer H, Sarrazin C, Hueppe D, Zehnter E, Manns MP.
Expert opinion on the treatment of patients with chronic hepatitis C.
J Viral Hepat. 2008 Aug 28. [Epub ahead of print] PMID: 18761607

Deterding K, Constantinescu I, Nedelcu FD, Gervain J, Nemecek V, Srtunecky O, Vince A, Grgurevic I, Bielawski KP, Zalewska M, Bock T, Ambrozaitis A, Stanczak J, Takács M, Chulanov V, Slusarczyk J, Drazd'áková M, Wiegand J, Cornberg M, Manns MP, Wedemeyer H.
Prevalence of HBV genotypes in Central and Eastern Europe.
J Med Virol. 2008 Oct;80(10):1707-11. PMID: 18712830

Lovric S, Erdbruegger U, Kümpers P, Woywodt A, Koenecke C, Wedemeyer H, Haller H, Haubitz M.
Rituximab as rescue therapy in anti-neutrophil cytoplasmic antibody-associated vasculitis: single centre experience with 15 patients.
Nephrol Dial Transplant. 2008 Aug 6. PMID: 18685144

Wiegand J, Wedemeyer H, Finger A, Heidrich B, Rosenau J, Michel G, Bock CT, Manns MP, Tillmann HL.
A decline in hepatitis B virus surface antigen (hbsag) predicts clearance, but does not correlate with quantitative hbeag or HBV DNA levels.
Antivir Ther. 2008;13(4):547-54. PMID: 18672533

Suneetha PV, Mederacke I, Heim A, Bastürk M, Cornberg M, Strassburg CP, Manns MP, Wedemeyer H.
Spontaneous clearance of chronic hepatitis C after liver transplantation: are hepatitis C virus-specific T cell responses the clue?
Liver Transpl. 2008 Aug;14(8):1225-7. PMID: 18668659

Fytili P, Dalekos GN, Schlaphoff V, Suneetha PV, Sarrazin C, Zauner W, Zachou K, Berg T, Manns MP, Klade CS, Cornberg M, Wedemeyer H.
Cross-genotype-reactivity of the immunodominant HCV CD8 T-cell epitope NS3-1073.
Vaccine. 2008 Jul 23;26(31):3818-26. PMID: 18582999

Veldt BJ, Chen W, Heathcote EJ, Wedemeyer H, Reichen J, Hofmann WP, de Knegt RJ, Zeuzem S, Manns MP, Hansen BE, Schalm SW, Janssen HL.
Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus.
Hepatology. 2008 Jun;47(6):1856-62. PMID: 18506898

Girke J, Wedemeyer H, Wiegand J, Manns MP, Tillmann HL.
[Acute hepatitis B: is antiviral therapy indicated? Two case reports]
Dtsch Med Wochenschr. 2008 May;133(22):1178-82. German. PMID: 18491273

Potthoff A, Wedemeyer H, Boecher WO, Berg T, Zeuzem S, Arnold J, Spengler U, Gruengreiff K, Kaeser T, Schuchmann M, Bergk A, Forestier N, Deterding K, Manns MP, Trautwein C; for the Hep-Net B/C Co-infection Study Group.
The HEP-NET B/C co-infection trial: A prospective multicenter study to investigate the efficacy of pegylated interferon-alpha2b and ribavirin in patients with HBV/HCV co-infection.
J Hepatol. 2008 Apr 29. PMID: 18490077

Klade CS, Wedemeyer H, Berg T, Hinrichsen H, Cholewinska G, Zeuzem S, Blum H, Buschle M, Jelovcan S, Buerger V, Tauber E, Frisch J, Manns MP.
Therapeutic vaccination of chronic hepatitis C nonresponder patients with the peptide vaccine IC41.
Gastroenterology. 2008 May;134(5):1385-95. Epub 2008 Mar 4. PMID: 18471515

Kaiser T, Damerow HC, Tenckhoff S, Finger A, Böttcher I, Hafer C, Schwarz A, Lüth JB, Schmidt Gürtler H, Colucci G, Manns MP, Wedemeyer H, Tillmann HL.
Kinetics of hepatitis C viral RNA and HCV-antigen during dialysis sessions: evidence for differential viral load reduction on dialysis.
J Med Virol. 2008 Jul;80(7):1195-201. PMID: 18461613

Deterding K, Wiegand J, Grüner N, Wedemeyer H.
Medical procedures as a risk factor for HCV infection in developed countries: do we neglect a significant problem in medical care?
J Hepatol. 2008 Jun;48(6):1019-20; author reply 1020-1. PMID: 18439703

Mauss S, Wedemeyer H.
Treatment of chronic hepatitis B and the implications of viral resistance to therapy.
Expert Rev Anti Infect Ther. 2008 Apr;6(2):191-9. Review. PMID: 18380601

Hadem J, Stiefel P, Bahr MJ, Tillmann HL, Rifai K, Klempnauer J, Wedemeyer H, Manns MP, Schneider AS.
Prognostic implications of lactate, bilirubin, and etiology in German patients with acute liver failure.
Clin Gastroenterol Hepatol. 2008 Mar;6(3):339-45. PMID: 18328438

Ciesek S, Helfritz FA, Lehmann U, Becker T, Strassburg CP, Neipp M, Ciner A, Fytili P, Tillmann HL, Manns MP, Wedemeyer H.
Persistence of occult hepatitis B after removal of the hepatitis B virus-infected liver.
J Infect Dis. 2008 Feb 1;197(3):355-60. PMID: 18248299

Pischke S, Cornberg M, Manns MP.
[Hepatitis associated cryoglobulinemia.]
Internist (Berl). 2008 Mar;49(3):297-304. German. PMID: 18327517

Ciesek S, Liermann H, Hadem J, Greten T, Tillmann HL, Cornberg M, Aslan N, Manns MP, Wedemeyer H.
Impaired TRAIL-dependent cytotoxicity of CD1c-positive dendritic cells in chronic hepatitis C virus infection.
J Viral Hepat. 2008 Mar;15(3):200-11. PMID: 18233993

Wölk B, Wedemeyer H.
Hepatitis C virus living off the fat of the land.
Hepatology. 2008 Jan;47(1):343-5. PMID: 18161719

 

 

Deterding K, Pothakamuri SV, Schlaphoff V, Hadem J, Metzler F, Bahr MJ, Manns MP, Cornberg M, Wedemeyer H.
Clearance of Chronic HCV Infection During Acute Delta Hepatitis.
Infection. 2007 Dec 14. PMID: 18084714

Cornberg M, Protzer U, Dollinger MM, Petersen J, Wedemeyer H, Berg T, Jilg W, Erhardt A, Wirth S, Schirmacher P, Fleig WE, Manns MP.
Prophylaxis, diagnosis and therapy of hepatitis B virus (HBV) infection: the German guidelines for the management of HBV infection.
Z Gastroenterol. 2007 Dec;45(12):1281-328. PMID: 18080231

Steffen M, Cornberg M, Buggisch P.
Treatment of chronic hepatitis C with consensus interferon in relapsers and non-responders to interferon-based therapy.
Hepatogastroenterology. 2007 Dec;54(80):2368-72. Review. PMID: 18265667

Ciesek S, Manns MP, Wedemeyer H.
Viral hepatitis after liver transplantation. Which immunosuppressive drugs should be recommended?
Minerva Gastroenterol Dietol. 2007 Dec;53(4):337-50. Review. PMID: 18043552

Veldt BJ, Heathcote EJ, Wedemeyer H, Reichen J, Hofmann WP, Zeuzem S, Manns MP, Hansen BE, Schalm SW, Janssen HL.
Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis.
Ann Intern Med. 2007 Nov 20;147(10):677-84. Summary for patients in: Ann Intern Med. 2007 Nov 20;147(10):I47. PMID: 18025443

Cooksley H, Chokshi S, Maayan Y, Wedemeyer H, Andreone P, Gilson R, Warnes T, Paganin S, Zoulim F, Frederick D, Neumann AU, Brosgart CL, Naoumov NV.
Hepatitis B virus e antigen loss during adefovir dipivoxil therapy is associated with enhanced virus-specific CD4+ T-cell reactivity.
Antimicrob Agents Chemother. 2008 Jan;52(1):312-20. PMID: 17984230

Potthoff A, Deterding K, Trautwein C, Rifai K, Manns MP, Wedemeyer H.
Sustained HCV-RNA response and hepatitis Bs seroconversion after individualized antiviral therapy with pegylated interferon alpha plus ribavirin and active vaccination in a hepatitis C virus/hepatitis B virus-coinfected patient.
Eur J Gastroenterol Hepatol. 2007 Oct;19(10):906-9. PMID: 17873617

Wedemeyer H, Cornberg M, Protzer U, Berg T, Dollinger MM.
[German guidelines on diagnosis and therapy of hepatitis B]
Dtsch Med Wochenschr. 2007 Aug;132(34-35):1775-82. Review. German. PMID: 17713890

Schlaphoff V, Klade CS, Jilma B, Jelovcan SB, Cornberg M, Tauber E, Manns MP, Wedemeyer H; IC41 Study Group.
Functional and phenotypic characterization of peptide-vaccine-induced HCV-specific CD8+ T cells in healthy individuals and chronic hepatitis C patients.
Vaccine. 2007 Sep 17;25(37-38):6793-806. Epub 2007 Jun 29. PMID: 17686555

Kubitschke A, Bader C, Tillmann HL, Manns MP, Kuhn S, Wedemeyer H.
[Injuries from needles contaminated with hepatitis C virus: how high is the risk of seroconversion for medical personnel really?]
Internist (Berl). 2007 Oct;48(10):1165-72. Review. German. PMID: 17684714

Fytili P, Tiemann C, Wang C, Schulz S, Schaffer S, Manns MP, Wedemeyer H.
Frequency of very low HCV viremia detected by a highly sensitive HCV-RNA assay.
J Clin Virol. 2007 Aug;39(4):308-11. Epub 2007 Jul 12. PMID: 17625963

Hadem J, Cornberg M, Länger F, Schedel I, Kirchhoff T, Niedermeyer J, Manns MP, Schöfl C.
Making sense of muscle fatigue and liver lesions.
Z Gastroenterol. 2007 Jul;45(7):609-11. PMID: 17620225

Wiegand J, Cornberg M, Aslan N, Schlaphoff V, Sarrazin C, Kubitschke A, Buggisch P, Ciner A, Jaeckel E, Manns MP, Wedemeyer H.
Fate and function of hepatitis-C-virus-specific T-cells during peginterferon-alpha2b therapy for acute hepatitis C.
Antivir Ther. 2007;12(3):303-16. PMID: 17591020

Meyer MF, Lehmann M, Cornberg M, Wiegand J, Manns MP, Klade C, Wedemeyer H.
Clearance of low levels of HCV viremia in the absence of a strong adaptive immune response.
Virol J. 2007 Jun 11;4:58. PMID: 17562015

Cornberg M, Protzer U, Dollinger MM, Petersen J, Wedemeyer H, Berg T, Jilg W, Erhardt A, Wirth S, Schirmacher P, Fleig WE, Manns MP.
[Prophylaxis, Diagnosis and Therapy of Hepatitis-B-Virus-(HBV-)Infection: upgrade of the guideline, AWMF-Register 021/011]
Z Gastroenterol. 2007 Jun;45(6):525-74. Epub 2007 Jun 6. German. PMID: 17554641

Wedemeyer H, Heidrich B, Manns MP.
Hepatitis D virus infection--not a vanishing disease in Europe!
Hepatology. 2007 May;45(5):1331-2; author reply 1332-3. PMID: 17464980

Rifai K, Wedemeyer H, Rosenau J, Klempnauer J, Strassburg CP, Manns MP, Tillmann HL.
Longer survival of liver transplant recipients with hepatitis virus coinfections.
Clin Transplant. 2007 Mar-Apr;21(2):258-64. PMID: 17425755

Lehmann U, Wingen LU, Brakensiek K, Wedemeyer H, Becker T, Heim A, Metzig K, Hasemeier B, Kreipe H, Flemming P.
Epigenetic defects of hepatocellular carcinoma are already found in non-neoplastic liver cells from patients with hereditary haemochromatosis.
Hum Mol Genet. 2007 Jun 1;16(11):1335-42. PMID: 17412760

Meyer MF, Wedemeyer H, Monazahian M, Dreesman J, Manns MP, Lehmann M.
Prevalence of hepatitis C in a German prison for young men in relation to country of birth.
Epidemiol Infect. 2007 Feb;135(2):274-80. PMID: 16824250

Potthoff A, Deterding K, Trautwein C, Flemming P, Strassburg CP, Manns MP, Wedemeyer H, Bahr MJ.
Steroid treatment for severe acute cryptogenic hepatitis.
Z Gastroenterol. 2007 Jan;45(1):15-9. PMID: 17236116

Kubitschke A, Bahr MJ, Aslan N, Bader C, Tillmann HL, Sarrazin C, Greten T, Wiegand J, Manns MP, Wedemeyer H.
Induction of hepatitis C virus (HCV)-specific T cells by needle stick injury in the absence of HCV-viraemia.
Eur J Clin Invest. 2007 Jan;37(1):54-64. PMID: 17181568

Trebst C, Wedemeyer H, Manns MP, Tillmann H, Windhagen A.
Treatment of hepatitis C virus-associated inflammatory polyneuropathy with pegylated interferon-alpha and ribavirin.
Eur J Gastroenterol Hepatol. 2007 Jan;19(1):91-2. PMID: 17206084

Cornberg M, Sheridan BS, Saccoccio FM, Brehm MA, Selin LK.
Protection against vaccinia virus challenge by CD8 memory T cells resolved by molecular mimicry.
J Virol. 2007 Jan;81(2):934-44. PMID: 17079318

 

Potthoff A, Tillmann HL, Bara C, Deterding K, Pethig K, Meyer S, Haverich A, Böker KH, Manns MP, Wedemeyer H.
Improved outcome of chronic hepatitis B after heart transplantation by long-term antiviral therapy.
J Viral Hepat. 2006 Nov;13(11):734-41. PMID: 17052272

Welsh RM, Kim SK, Cornberg M, Clute SC, Selin LK, Naumov YN.
The privacy of T cell memory to viruses.
Curr Top Microbiol Immunol. 2006;311:117-53. Review. PMID: 17048707

Deterding K, Tegtmeyer B, Cornberg M, Hadem J, Potthoff A, Böker KH, Tillmann HL, Manns MP, Wedemeyer H.
Hepatitis A virus infection suppresses hepatitis C virus replication and may lead to clearance of HCV.
J Hepatol. 2006 Dec;45(6):770-8. PMID: 17034895

Cornberg M, Deterding K, Manns MP.
Present and future therapy for hepatitis C virus.
Expert Rev Anti Infect Ther. 2006 Oct;4(5):781-93. Review. PMID: 17140355

Wedemeyer H, Cornberg M, Wiegand J, Manns M.
Treatment duration in acute hepatitis C: the issue is not solved yet.
Hepatology. 2006 Oct;44(4):1051; author reply 1051-2. PMID: 17006944

Rosenau J, Hooman N, Rifai K, Solga T, Tillmann HL, Grzegowski E, Nashan B, Klempnauer J, Strassburg CP, Wedemeyer H, Manns MP.
Hepatitis B virus immunization with an adjuvant containing vaccine after liver transplantation for hepatitis B-related disease: failure of humoral and cellular immune response.
Transpl Int. 2006 Oct;19(10):828-33. PMID: 16961775

Manns MP, Wedemeyer H, Cornberg M.
Treating viral hepatitis C: efficacy, side effects, and complications.
Gut. 2006 Sep;55(9):1350-9. Review. PMID: 16905701

Aslan N, Yurdaydin C, Wiegand J, Greten T, Ciner A, Meyer MF, Heiken H, Kuhlmann B, Kaiser T, Bozkaya H, Tillmann HL, Bozdayi AM, Manns MP, Wedemeyer H.
Cytotoxic CD4 T cells in viral hepatitis.
J Viral Hepat. 2006 Aug;13(8):505-14. PMID: 16901280

Wedemeyer H, Cornberg M, Wiegand J, Jäckel E, Manns MP.
Treatment of acute hepatitis C-how to explain the differences?
Gastroenterology. 2006 Aug;131(2):682-3; author reply 683-4. PMID: 16890627

Kronenberger B, Herrmann E, Hofmann WP, Wedemeyer H, Sester M, Mihm U, Ghaliai T, Zeuzem S, Sarrazin C.
Dynamics of CD81 expression on lymphocyte subsets during interferon-alpha-based antiviral treatment of patients with chronic hepatitis C.
J Leukoc Biol. 2006 Aug;80(2):298-308. PMID: 16735696

Selin LK, Brehm MA, Naumov YN, Cornberg M, Kim SK, Clute SC, Welsh RM.
Memory of mice and men: CD8+ T-cell cross-reactivity and heterologous immunity.
Immunol Rev. 2006 Jun;211:164-81. Review. PMID: 16824126

Volkmann X, Cornberg M, Wedemeyer H, Lehner F, Manns MP, Schulze-Osthoff K, Bantel H.
Caspase activation is required for antiviral treatment response in chronic hepatitis C virus infection.
Hepatology. 2006 Jun;43(6):1311-6. PMID: 16729308

Cornberg M, Chen AT, Wilkinson LA, Brehm MA, Kim SK, Calcagno C, Ghersi D, Puzone R, Celada F, Welsh RM, Selin LK.
Narrowed TCR repertoire and viral escape as a consequence of heterologous immunity.
J Clin Invest. 2006 May;116(5):1443-56. Erratum in: J Clin Invest. 2007 May;117(5):1450. PMID: 16614754

Ormandy LA, Farber A, Cantz T, Petrykowska S, Wedemeyer H, Horning M, Lehner F, Manns MP, Korangy F, Greten TF.
Direct ex vivo analysis of dendritic cells in patients with hepatocellular carcinoma.
World J Gastroenterol. 2006 May 28;12(20):3275-82. PMID: 16718852

Tillmann HL, Hadem J, Leifeld L, Zachou K, Canbay A, Eisenbach C, Graziadei I, Encke J, Schmidt H, Vogel W, Schneider A, Spengler U, Gerken G, Dalekos GN, Wedemeyer H, Manns MP.
Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience.
J Viral Hepat. 2006 Apr;13(4):256-63. PMID: 16611192

Fytili P, Ciesek S, Manns MP, Wedemeyer H, Neipp M, Helfritz F, Klempnauer J, Bara C, Haverich A.
Anti-HBc seroconversion after transplantation of anti-HBc positive nonliver organs to anti-HBc negative recipients.
Transplantation. 2006 Mar 15;81(5):808-9. PMID: 16534488

Wiegand J, Buggisch P, Boecher W, Zeuzem S, Gelbmann CM, Berg T, Kauffmann W, Kallinowski B, Cornberg M, Jaeckel E, Wedemeyer H, Manns MP; German HEP-NET Acute HCV Study Group.
Early monotherapy with pegylated interferon alpha-2b for acute hepatitis C infection: the HEP-NET acute-HCV-II study.
Hepatology. 2006 Feb;43(2):250-6. PMID: 16440367

Meyer S, Manns MP, Wedemeyer H.
[Three years of vertical networking in the German Network of Competence on Viral Hepatitis: what can we learn from the usage of different information tools?]
Z Gastroenterol. 2006 Jan;44(1):15-23. German. PMID: 16397835

Cornberg M, Hadem J, Herrmann E, Schuppert F, Schmidt HH, Reiser M, Marschal O, Steffen M, Manns MP, Wedemeyer H.
Treatment with daily consensus interferon (CIFN) plus ribavirin in non-responder patients with chronic hepatitis C: a randomized open-label pilot study.
J Hepatol. 2006 Feb;44(2):291-301. PMID: 16360972